Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published February 21, 2012 | Published + Supplemental Material
Journal Article Open

Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane

Abstract

Despite being engineered to avoid renal clearance, many cationic polymer (polycation)-based siRNA nanoparticles that are used for systemic delivery are rapidly eliminated from the circulation. Here, we show that a component of the renal filtration barrier—the glomerular basement membrane (GBM)—can disassemble cationic cyclodextrin-containing polymer (CDP)-based siRNA nanoparticles and, thereby, facilitate their rapid elimination from circulation. Using confocal and electron microscopies, positron emission tomography, and compartment modeling, we demonstrate that siRNA nanoparticles, but not free siRNA, accumulate and disassemble in the GBM. We also confirm that the siRNA nanoparticles do not disassemble in blood plasma in vitro and in vivo. This clearance mechanism may affect any nanoparticles that assemble primarily by electrostatic interactions between cationic delivery components and anionic nucleic acids (or other therapeutic entities).

Additional Information

© 2012 by the National Academy of Sciences. Freely available online through the PNAS open access option. Contributed by Mark E. Davis, January 17, 2012 (sent for review December 22, 2011). We thank Paul Webster (House Ear Institute) for providing equipment for TEM sample preparation and Carol M. Garland (California Institute of Technology) and Dr. Alasdair McDowall (California Institute of Technology) for help obtaining electron microscopy images. This work benefited from the use of the California Institute of Technology Materials Science TEM facility, which is partially supported by the Materials Research Science & Engineering Center Program of the National Science Foundation under Award DMR-0520565. We thank Derek W. Bartlett and Isabel J. Hildebrandt for performing the PET experiments and Devin Wiley for reading the manuscript and discussion. This work was supported by National Cancer Institute Grant CA119347 and Sanofi-Aventis. J.E.Z. is also supported by the California Institute of Technology- University of California, Los Angeles Joint Center for Translational Medicine. Author contributions: J.E.Z. and M.E.D. designed research; J.E.Z., C.H.J.C., and H.H. performed research; J.E.Z., C.H.J.C., H.H., and M.E.D. analyzed data; and J.E.Z., C.H.J.C., and M.E.D. wrote the paper. The authors declare no conflict of interest.

Attached Files

Published - Zuckerman2012p17378P_Natl_Acad_Sci_Usa.pdf

Supplemental Material - sapp.pdf

Files

sapp.pdf
Files (1.9 MB)
Name Size Download all
md5:08f0db88f20305d673507e746d59d49b
621.6 kB Preview Download
md5:faea00064be0cca31dd21e0fe0a42e75
1.3 MB Preview Download

Additional details

Created:
August 22, 2023
Modified:
October 24, 2023